Cost effectiveness analysis
Cost effectiveness analysis evaluates the costs and consequences of health interventions by employing decision analytic models to synthesize data derived from clinical trials, stand-alone studies, retrospective administrative database analyses, and systematic review of published literature. Cost effectiveness analysis is increasingly central to reimbursement decision-making, whether formally by national and regional reimbursement authorities, or informally by decision-makers in private healthcare agencies.
Oxford Outcomes is an international market leader in cost effectiveness analysis. Our Health Economics team has a wealth of research and consulting expertise in economic evaluations, and utilizes its scientific strengths alongside commercial and regulatory knowledge to achieve reliable and highly-credible results for our clients. For more about our team click here, and for recent publications click here.
Our team design and build economic models with the scientific rigor to powerfully and credibly communicate cost effectiveness to national and regional reimbursement authorities and healthcare providers. Our models employ tried-and-tested, as well as state-of-the-art methods including fully probabilistic analyses of uncertainty, value-of-information analyses and detailed sub-group analysis. We ensure quality control by conducting parallel programming for each model and by incorporating detailed analysis of assumptions, risk and uncertainty associated with study design and the state of knowledge surrounding data and values.